The market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session.
By Mill Chart
Last update: Apr 29, 2024
These stocks are gapping in today's session
Today's gap up stocks
| Ticker | Change | Comment |
|---|---|---|
| DCPH | 72.08% | DECIPHERA PHARMACEUTICALS IN's (NASDAQ:DCPH) shares rose 72.08% to $25.21 with a gap of 69.61% during Monday's session. The company is releasing earnings today. Earlier today the company had a press release: DCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Deciphera Pharmaceuticals, Inc. Is Fair to Shareholders. |
| CAUD | 70.85% | COLLECTIVE AUDIENCE INC's (NASDAQ:CAUD) stock price increased by 70.85% to $0.67 with a gap of 27.71%. Shareholders saw the stock price going 37.7% lower in the past month. |
| SLNO | 36.24% | In today's session, SOLENO THERAPEUTICS INC's (NASDAQ:SLNO) stock experienced a notable rise of 36.24%, reaching $51.62 with a significant 21.11% gap. The stock is trading 68.25% higher than 6 months ago. |
| PHG | 32.65% | KONINKLIJKE PHILIPS NVR- NY's (NYSE:PHG) shares soared 32.65% to $27.95 in Monday's session, displaying an impressive 31.39% gap. KONINKLIJKE PHILIPS NVR- NY released earnings Yesterday. |
| SINT | 32.43% | SINTX TECHNOLOGIES INC's (NASDAQ:SINT) shares surged 32.43% to $0.05 with a remarkable gap of 9.52%. The stock is trading 86.52% lower than 3 months ago. |
| IBRX | 24.9% | During Monday's session, IMMUNITYBIO INC's (NASDAQ:IBRX) stock price showed a remarkable increase of 24.9%, reaching $9.18 with a notable 7.62% gap. In the last month the stock gained 36.87%. |
| BTOG | 18.98% | During Monday's session, BIT ORIGIN LTD's (NASDAQ:BTOG) stock price showed a remarkable increase of 18.98%, reaching $3.95 with a notable 7.78% gap. The stock is trading 27.53% lower than 3 months ago. |
| PAHC | 17.36% | PHIBRO ANIMAL HEALTH CORP-A's (NASDAQ:PAHC) shares rose 17.36% to $14.94 with a gap of 6.0%. Yesterday the company had a press release: Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal Health. |
| MULN | 16.95% | MULLEN AUTOMOTIVE INC's (NASDAQ:MULN) shares soared 16.95% to $3.7 during Monday's session, accompanied by a significant gap of 2.54%. A press release (California Issues HVIP Approval, Granting Mullen’s Class 3 EV Trucks a $45,000 Cash Voucher Per Vehicle Sold) was released earlier today. |
| HTLF | 16.78% | During Monday's session, HEARTLAND FINANCIAL USA INC's (NASDAQ:HTLF) stock price showed a remarkable increase of 16.78%, reaching $41.72 with a notable 11.45% gap. NASDAQ:HTLF is releasing earnings today. Earlier today the company had a press release: HTLF Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Heartland Financial, USA Inc. Is Fair to Shareholders. |
For the full gap up stocks list go to our gap up stocks screener.
Today's top gap down stocks
| Ticker | Change | Comment |
|---|---|---|
| IONM | -27.66% | Today, ASSURE HOLDINGS CORP's (NASDAQ:IONM) stock experienced a 27.66% fall to $0.5 with a 62.13% gap. In the last month the stock gained 42.07%. |
| ATXI | -23.06% | AVENUE THERAPEUTICS INC's (NASDAQ:ATXI) shares fell 23.06% to $4.77 during Monday's session with a gap of 47.05%. Earlier today the company had a press release: Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds. |
| CJJD | -19.43% | CHINA JO-JO DRUGSTORES HOLDI's (NASDAQ:CJJD) shares experienced a 19.43% decline to $2.28 during Monday's session, accompanied by a 32.99% gap. Shareholders saw the stock price going 22.44% lower in the past 3 months. |
| RWODR | -17.5% | In today's session, REDWOODS ACQUISITION-RIGHTS's (NASDAQ:RWODR) stock witnessed a 17.5% fall to $0.23 with a 20.32% gap. Shareholders saw the stock price going 75.0% higher in the past 3 months. |
| ANVS | -16.71% | Today, ANNOVIS BIO's (NYSE:ANVS) stock experienced a 16.71% fall to $15.0 with a 19.67% gap. Earlier today the company had a press release: Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease. |
| FFIE | -16.38% | FARADAY FUTURE INTELLIGENT E's (NASDAQ:FFIE) shares fell 16.38% to $0.04 with a gap of 26.92%. In the last month the stock lost 53.0%. |
| AQST | -14.25% | AQUESTIVE THERAPEUTICS INC's (NASDAQ:AQST) shares recorded a 14.25% decline to $3.49, with a notable 23.52% gap during today's session. Earlier today the company had a press release: Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film. |
| ISUN | -13.33% | ISUN INC's (NASDAQ:ISUN) shares fell 13.33% to $0.15 with a gap of 23.68%. Shareholders saw the stock price going 32.8% lower in the past month. |
| SLS | -13.05% | Unfavorable news for SELLAS LIFE SCIENCES GROUP I's (NASDAQ:SLS) stock! It witnessed a 13.05% decline to $1.27 in today's session, along with a 22.33% gap. In the last month the stock gained 44.55%. |
| VIVK | -12.59% | In today's session, VIVAKOR INC's (NASDAQ:VIVK) stock price decreased by 12.59% to $1.18, exhibiting a 26.39% gap. Shareholders saw the stock price going 70.84% higher in the past month. |
Our gap down stocks screener will show you the full list.
AQUESTIVE THERAPEUTICS INC
NASDAQ:AQST (5/9/2024, 9:54:07 AM)
3.285
+0.2 (+6.31%)
AQST News
3 hours ago - Aquestive Therapeutics, Inc.Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences ConferenceWARREN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to bring...
2 days ago - InvestorPlaceAQST Stock Earnings: Aquestive Therapeutics Misses EPS, Misses Revenue for Q1 2024AQST stock results show that Aquestive Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
2 days ago - BusinessInsiderAQST Stock Earnings: Aquestive Therapeutics Misses EPS, Misses Revenue for Q1 2024InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aquestive Therapeutics (NASDAQ:AQST) just reported results for the first quarte...
2 days ago - Aquestive Therapeutics, Inc.Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateMet all endpoints in Phase 3 pivotal study for Anaphylm™ (epinephrine) Sublingual Film in first quarter 2024 when compared to EpiPen® and other injectors...
10 days ago - ChartmillThe market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session.These stocks are gapping in today's session
10 days ago - Aquestive Therapeutics, Inc.Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film14 days ago - Aquestive Therapeutics, Inc.Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET
22 days ago - InvestorPlaceComing FDA Approvals Could Send These 3 Drug Stocks SoaringWhen it comes to drug stocks, FDA approval can bring years or even decades of steady, high-margin revenue.
a month ago - Aquestive Therapeutics, Inc.Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of NeurologyWARREN, N.J., April 12, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company” or “Aquestive”), a pharmaceutical company...
